FAS and FASLG Genetic Variants and Risk for Second Primary Malignancy in Patients With Squamous Cell Carcinoma of the Head and Neck

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-10-0030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

P73G4C14-To-A4t14 Polymorphism and Risk of Second Primary Malignancy After Index Squamous Cell Carcinoma of Head and Neck

International Journal of Cancer
Cancer ResearchOncology
2009English

Pulmonary Squamous Cell Carcinoma Following Head and Neck Squamous Cell Carcinoma: Metastasis or Second Primary?

Clinical Cancer Research
Cancer ResearchOncology
2005English

Genetic Variants in Selected Pre-microRNA Genes and the Risk of Squamous Cell Carcinoma of the Head and Neck

Cancer
Cancer ResearchOncology
2010English

Risk of Second Primary Malignancy in Head and Neck Cancer Patients: A Population-Based Study

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

The Effect of Second Hand Smoke in Patients With Squamous Cell Carcinoma of the Head and Neck

Journal of Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2019English

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation
Medicine
2016English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Genetic Analysis of Head and Neck Squamous Cell Carcinoma and Surrounding Mucosa

Archives of Otolaryngology–Head & Neck Surgery
1999English

Extranodal Spread of Primary and Secondary Metastatic Nodes: The Dominant Risk Factor of Survival in Patients With Head and Neck Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy